Smith+Nephew unveils ‘Precision in Motion’ for its Orthopaedics Arthroplasty portfolio at AAOS 2023 Annual Meeting

March 9, 2023
by

Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, today unveils “Precision in Motion”, a franchise-level value proposition spanning its Robotics, Knee, and Hip portfolios within the Orthopaedics business. It underscores Smith+Nephew’s promise to deliver an uncompromising commitment to freedom of movement by focusing on three key elements– personalizing surgery, advancing efficiency, and optimizing performance.

“Precision speaks directly to our technology business. The ability to deliver accuracy and precision is at the core of our robotics platform, while ‘in motion’ activates the implant franchises. The combination of these portfolios will enable surgeons to best manage patient needs,” noted Randy Kilburn, EVP and GM of Smith+Nephew Orthopaedics. “Precision in Motion embodies the strategic direction of the Orthopaedic business. Focusing the portfolio in this manner will showcase current products and future investments aligned to customer needs. We have the ability now to personalize surgery, advance efficiency, and optimize performance with our implant and enabling technology portfolios”.

Personalizing Surgery

By combining technologies like RI.KNEE and RI.HIP NAVIGATION with JOURNEY II Total Knee Arthroplasty, POLAR3 Total Hip Solution, and the OR3O Dual Mobility Hip System, Smith+Nephew delivers solutions that give surgeons the ability to place the implant based on individual patient anatomy.

“Combining an implant that was designed to restore shape, position, and motion of the normal knee, with our new Digital Tensioner will allow surgeons to collect individual knee tension – this will be a game changer for us”, stated Michelle Paknad, VP, Global Marketing – Robotics and Digital Technologies at Smith+Nephew.

Advancing Efficiency

“With so much emphasis on efficiency, we are thrilled to help customers make the complex as simple as possible,” noted Tim Bourne, VP, Global Marketing – Knees at Smith+Nephew. We are proud to be the only company in the US to offer a fully cementless partial knee with the ENGAGE Cementless Partial Knee System.

Smith+Nephew now offers the first and only robotic revision indication in the US with RI.KNEE ROBOTICS – combining the CORI Surgical System and LEGION RK System with OXINIUM Technology. A robotics solution that provides surgeons with precision technology, enabling them to manage bony defects and joint line restoration in these difficult cases.

Optimizing Performance

“Smith+Nephew is optimizing performance by providing innovative, patient-centric, implant and technology solutions that work together to solve the clinical problems our customers face”, stated Simran Sabharwal, VP, Global Marketing – Hips at Smith+Nephew. “Hip instability is the most common cause for revision, after infection. We are the only company that can offer a CoCr-free modular dual mobility solution, the OR3O Dual Mobility System, building on the proven performance of our OXINIUM Technology.”

To learn more about the latest advancements in orthopaedic reconstruction and robotics, please stop by the Smith+Nephew booth (#2021) during AAOS 2023.

About Smith+Nephew

Smith+Nephew is a portfolio medical technology company focused on the repair, regeneration and replacement of soft and hard tissue. We exist to restore people’s bodies and their self-belief by using technology to take the limits off living. We call this purpose ‘Life Unlimited’. Our 19,000 employees deliver this mission every day, making a difference to patients’ lives through the excellence of our product portfolio, and the invention and application of new technologies across our three global franchises of Orthopaedics, Sports Medicine & ENT and Advanced Wound Management.

Founded in Hull, UK, in 1856, we now operate in more than 100 countries, and generated annual sales of $5.2 billion in 2022. Smith+Nephew is a constituent of the FTSE100 (LSE: SN, NYSE: SNN). The terms ‘Group’ and ‘Smith+Nephew’ are used to refer to Smith & Nephew plc and its consolidated subsidiaries, unless the context requires otherwise.

For more information about Smith+Nephew, please visit www.smith-nephew.com.

Cision

Leave a Reply

Your email address will not be published.

Don't Miss

Leicestershire’s 35 Fastest Growing Industrial Startups

At Best Startup London we track over 100,000 London based startups and

Harrow’s 5 Fastest Growing Electronics Startups

At Best Startup London we track over 100,000 London based startups and